Yanhua Ding

13PUBLICATIONS
11CO-AUTHORS
PharmacogenomicsCheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesDiagnostic radiographyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 15, 2026
Pharmacokinetics, safety, and dose optimization of GST-HG171 in renal impairment: insights from physiologically based pharmacokinetic modeling.

|May 11, 2026
Pharmacokinetic drug-drug interaction between the COVID-19 3CL protease inhibitor GST-HG171 and itraconazole in healthy subjects.

|Jan 13, 2026
Pharmacokinetics and safety of HR17031, a fixed-ratio of INS068/Noiiglutide combination, in Chinese patients with hepatic impairment.

Di Wang, Xuehu Gao, Jiajia Mai

|Apr 15, 2025
A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male Subjects.

Jia Xu, Junyou Ge, Yaling Li

|Jan 31, 2025
Single- and multiple-dose pharmacokinetics and safety of the SARS-CoV-2 3CL protease inhibitor RAY1216: a phase 1 study in healthy participants.

Yue Hu, Haijun Li, Kun Wang

|Dec 17, 2024
Single-dose tolerability and pharmacokinetics of leritrelvir in Chinese patients with hepatic impairment and healthy matched controls.

Cuiyun Li, Jiajia Mai, Min Wu

Pageof 3

Frequent Collaborators

2 joint publications

Yue Hu

2 joint publications

Junqi Niu

2 joint publications

Hong Zhang

2 joint publications

Min Wu